Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$56.91 - $127.53 $5,975 - $13,390
-105 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$79.79 - $126.29 $1,595 - $2,525
-20 Reduced 16.0%
105 $10,000
Q4 2020

Jan 13, 2021

BUY
$46.76 - $136.27 $3,507 - $10,220
75 Added 150.0%
125 $10,000
Q3 2020

Nov 12, 2020

BUY
$43.8 - $77.2 $2,190 - $3,860
50 New
50 $2,000

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $538M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.